Skip to search formSkip to main contentSkip to account menu

PD 148903

Known as: PD-148903, PD148903 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

2-Naphthylamine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Analogs of PD148903 – Orally Active Anti-Parkinsonian Prodrugs
A series of analogs of the enone prodrug PD148903 (2.3), having different Nsubstituents, were synthesized and pharmacologically… 
2002
2002
Oxime derivatives of PD217015 and PD148903. Orally active anti-Parkinson cascade prodrugs
A series of oxime ether and oxime ester derivatives of the potential anti-Parkinson prodrug PD148903 (2.3) were synthesized and… 
2002
2002
Analogs of PD 148903 – Orally Active Anti-Parkinsonian Prodrugs
A series of analogs of the enone prodrug PD148903 (2.3), having different Nsubstituents, were synthesized and pharmacologically… 
2002
2002
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.
After decades of research around dopamine agonists, we have found a promising compound in S-PD148903 that represents a new type… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)